Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Controlled Trial to Investigate Combined Occipital and Supra-orbital Neuromodulation in Resistant Migraine. The RECLAIM Study.

NCT06450444 is registered in ClinicalTrials.gov with Salvia BioElectronics as lead sponsor.

NCT NCT06450444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06450444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Controlled Trial to Investigate Combined Occipital and Supra-orbital Neuromodulation in Resistant Migraine. The RECLAIM Study.
Lead sponsor
Salvia BioElectronics
Phase
Not applicable
Overall status
Recruiting
Start date
June 24, 2024
Completion date
January 31, 2029
Enrollment
110 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, high frequency episodic migraine